Portfolio company
CaSRevolution
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops therapies for Alzheimer's disease by creating molecules that target the calcium-sensing receptor to halt neurodegeneration.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MindImmune
This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Kalgene
This biotechnology company develops precision medicine therapeutics and companion diagnostics to treat Alzheimer's disease and various cancers for patients and clinical providers.
Korsana Biosciences
This biotechnology company develops brain-penetrant therapeutics for patients with neurodegenerative conditions such as Alzheimer's disease.
AstronauTx
This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
Monument Biosciences
This biotechnology company develops disease-modifying drugs and translational biomarkers to treat Alzheimer's disease and related dementias.
AZ Therapies
This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.
